The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
The TGA today represents the product of a long history of evolution of therapeutic products regulation in Australia. This publication aims to capture this evolutionary process not only as an interesting example of the development and role of a regulator but also to understand the directions for the future.
This book covers the periods from the early 1900s up to 2007.
About the author
Dr John McEwen graduated in pharmacy at the Victorian College of Pharmacy and as a Master of Science in Neurophysiology at Melbourne University. After a period as lecturer in Physiology, he completed medical training and house positions at Royal Melbourne Hospital.
For ten years from 1979, Dr McEwen was Secretary of the Adverse Drug Reactions Advisory Committee and subsequently Head, Drug Evaluation Support Branch. During this time, he was a member and later Chairman of the Advisory Board to the WHO Collaborating Centre for International Drug Monitoring based in Uppsala, Sweden and also acted as Editor of Australian Prescriber.
In 1994, Dr McEwen returned to the Therapeutic Goods Administration after five years as Medical Director, CSL Ltd, Melbourne. Dr McEwen became the TGA's Principal Medical Advisor in 2002 and retired from the TGA in 2005.
Get a copy
This book is available as a free PDF download from this website or as a softcover printed book for $25 including postage within Australia. You can purchase the softcover version by completing a publication order form.